BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

  April 24, 2026

   · 

  1 min read
• Press Releases

  Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)

  April 24, 2026

   · 

  4 min read
• Press Releases

  Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

  April 24, 2026

   · 

  4 min read
• Press Releases

  TPX-100: OrthoTrophix Presents New Data Revealing Structural Coupling between Femoral Bone Shape and Meniscal Pathology in Knee Osteoarthritis

  April 24, 2026

   · 

  4 min read
• Press Releases

  Circular Genomics Appoints World-Renowned Expert in Neurochemistry and Alzheimer’s Fluid Biomarkers Dr. Henrik Zetterberg to Scientific Advisory Board

  April 24, 2026

   · 

  3 min read
• Press Releases

  Medytox Holds 2026 Global Anatomy Workshop in Bangkok

  April 24, 2026

   · 

  3 min read
• Press Releases

  iSpecimen Announces 1-for-40 Reverse Stock Split

  April 24, 2026

   · 

  4 min read
• 

  Psychedelics

  FDA awards priority vouchers to 3 undisclosed companies for investigational psychedelics

  While the FDA did not announce the recipient names of the Commissioner’s National Priority Vouchers, the agency’s descriptions of the awarded products match those in development at Compass Pathways, Transcend Therapeutics and Usona Institute.

  April 24, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  BYT Holdings Ltd. Announces Delay of Annual Filings and Application for a Management Cease Trade Order

  April 24, 2026

   · 

  4 min read